Ji. Asaumi et al., Influence of metabolic inhibitors on the intracellular accumulation and retention of adriamycin, ANTICANC R, 19(1A), 1999, pp. 615-618
We observed modulation of the intracellular accumulation and retention of a
driamycin (ADR) by metabolic inhibitors in Ehrlich ascites tumor cells (wil
d type EAT cells) and their ADR-resistant EAT strain. In the wild type EAT
cells, ADR accumulation was increased by 0.2 mM of 2,4-dinitrophenol (2,4-D
NP), 1 mM of sodium azide (NaN3) or 1 mM of potassium cyanide (KCN), which
were the metabolic inhibitors and its efflux was inhibited by the metabolic
inhibitors several fold. These results indicate that in wild type EAT cell
s, one of the mechanisms which increase the intracellular accumulation of A
DR involve inhibition of efflux which may be inhibited by these metabolic i
nhibitors. In ADR-resistant EAT strain 2,4-DNP or KCN increased the ADR acc
umulation, but NaN3 did nor affect it. Further; ADR efflux in the ADR-resis
tant cells after incubation with the metabolic inhibitors were similar to t
hat found in the control. These indicates that in the ADR-resistant cells,
NaN3 does not affect ADR accumulation and retention, and that the increase
in the ADR accumulation by KCN and 2,4-DNP was considered to be due to the
influx rather than efflux. In addition, 2,4-DNP, NaN3 or KCN inhibited ADR
efflux in the wild type GAT cells but not in the ADR-resistant EAT strain.
These suggests that there is an efflux mechanism in the ADR-resistant EAT s
train that involves an energy system that differs from the energy system in
wild type EAT cells or does not depend on energy produced by the metabolic
inhibitors.